USP9X

Ubiquitin carboxyl-terminal hydrolase 9X · Q93008 · USP9X on Sugi Atlas →

4,084 patent compounds predicted against USP9X, 1,952 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL882501 SCHEMBL882501 1.00 11/20
SCHEMBL1317669 SCHEMBL1317669 1.00 11/20
SCHEMBL1317671 SCHEMBL1317671 1.00 11/20
SCHEMBL1317674 SCHEMBL1317674 1.00 11/20
SCHEMBL864885 SCHEMBL864885 0.85 11/20
SCHEMBL864886 SCHEMBL864886 0.85 11/20
SCHEMBL859666 SCHEMBL859666 0.81 11/20
SCHEMBL859667 SCHEMBL859667 0.81 11/20
SCHEMBL864393 SCHEMBL864393 0.81 11/20
SCHEMBL840599 SCHEMBL840599 0.79 11/20
SCHEMBL840600 SCHEMBL840600 0.79 11/20
SCHEMBL864115 SCHEMBL864115 0.78 11/20
SCHEMBL864116 SCHEMBL864116 0.78 11/20
SCHEMBL864117 SCHEMBL864117 0.78 11/20
SCHEMBL864118 SCHEMBL864118 0.78 11/20
SCHEMBL13349344 SCHEMBL13349344 0.78 11/20
SCHEMBL10124900 SCHEMBL10124900 0.78 11/20
SCHEMBL864194 SCHEMBL864194 0.75 11/20
SCHEMBL864195 SCHEMBL864195 0.75 11/20
SCHEMBL10124840 SCHEMBL10124840 0.72 11/20

Clinical trials — most relevant to USP9X by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma PHASE2WITHDRAWN
Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure PHASE2COMPLETED
Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma PHASE2SUSPENDED
Desferal Administration to Improve the Impaired Reaction to Hypoxia in Diabetes PHASE2UNKNOWN
The Effect of Roxadustat on Renal Oxygenation in Diabetes Nephropathy PHASE2NOT_YET_RECRUITING
Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers PHASE2NOT_YET_RECRUITING
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
The Danish TURNER Cryopreservation Study nanRECRUITING
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia nanUNKNOWN
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma nanCOMPLETED
Diagnostic Potential of UCHL1 in Acute Decompensated Heart Failure nanCOMPLETED
Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1 nanRECRUITING
New Signaling Pathway Targeting Systemic Lupus Erythematosus nanUNKNOWN
Effect of Dietary Nitrate on Immobilization-induced Changes in Skeletal Muscle in Young Healthy Men nanRECRUITING
HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC) nanCOMPLETED
DDX3X Syndrome -The Seaver Autism Center for Research and Treatment is Characterizing DDX3X-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. nanCOMPLETED
Better Delineation of DDX3X Related Phenotype and Epigenetic Signature. nanUNKNOWN
Low Dose Melphalan and Bortezomib for AML and High-Risk MDS nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders nanCOMPLETED
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
Chromosome 9 P Minus Syndrome nanRECRUITING
Exercise Therapy to Reduce Heart Failure Symptoms; Sorting Mechanisms of Benefit nanCOMPLETED
Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors nanNOT_YET_RECRUITING
HRQoL and Financial Toxicity in Patients With VEXAS Syndrome nanRECRUITING
Whole Genome Scan of Extended Families With Familial Vocal Cord Paralysis nanCOMPLETED
Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome nanRECRUITING
Genomic Analysis of Families With a History of Discordant Cancers nanRECRUITING
Inhibition of SENP1 for the Suppression of OS Growth and Metastasis nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a USP9X binder may also engage these)

ProteinNameSimilarity
P70398 1.000 P70398 →
O00507 0.988 O00507 →
Q8IWV8 0.985 Q8IWV8 →
Q7TPD0 0.984 Q7TPD0 →
Q86X10 0.983 Q86X10 →
Q96JJ3 0.981 Q96JJ3 →
Q8BHL5 0.980 Q8BHL5 →
Q5R644 0.980 Q5R644 →
O35841 0.979 O35841 →
Q68E01 0.979 Q68E01 →
Q9R1D7 0.979 Q9R1D7 →
Q7Z3J2 0.978 Q7Z3J2 →
Q5R8N4 0.978 Q5R8N4 →
P86410 0.977 P86410 →
Q8BWQ6 0.977 Q8BWQ6 →
Q924Z6 0.977 Q924Z6 →
Q8BQZ4 0.976 Q8BQZ4 →
Q08BT5 0.976 Q08BT5 →
Q5RE70 0.976 Q5RE70 →
Q5RCC1 0.975 Q5RCC1 →
Q6QI06 0.974 Q6QI06 →
Q9BZ29 0.973 Q9BZ29 →
XPO6 Exportin-6 0.973 landscape →
Q96PE3 0.973 Q96PE3 →
Q9P260 0.973 Q9P260 →
A4FUD6 0.973 A4FUD6 →
Q6P6Y1 0.973 Q6P6Y1 →
Q5XI83 0.973 Q5XI83 →
Q6DFZ1 0.972 Q6DFZ1 →
Q8IZD9 0.972 Q8IZD9 →